){kind=logo}
With a flood of new CBD products on the market, there are also an increasing number of lawsuits emerging from concerns upon how these products are marketed. Loeb & Loeb Associate Christopher Binns explores the FDA regulatory environment of CBD products and how marketing and advertisements play a substantive role in compliance.
Click here to read the full article on the Law360 website.